Publisher： Cambridge University Press
E-ISSN： 1481-8035|7|4|262-265
ISSN： 1481-8035
Source： Canadian Journal of Emergency Medicine, Vol.7, Iss.4, 2005-07, pp. : 262-265
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Wolff–Parkinson–White (WPW) syndrome with atrial fibrillation (AF) is a potentially life-threatening problem requiring rapid conversion to sinus rhythm. The most recent American Heart Association guidelines for the treatment of patients with WPW, published in conjunction with the 2000 Advanced Cardiac Life Support (ACLS) guidelines, suggests that intravenous amiodarone is a first-line therapy for AF–WPW; however the evidence suggests this is a potentially dangerous myth.
Related content
Access to resources
Recommend
By Svendsen Jesper Hastrup Dagres Nikolaos Dobreanu Dan Bongiorni Maria Grazia Marinskis Germanas Blomström-Lundqvist Carina
EP-Europace, Vol. 15, Iss. 5, 2013-05 ,pp. :
Wolff–Parkinson–White syndrome: lessons learnt and lessons remaining
Cardiology in the Young, Vol. 27, Iss. S1, 2017-01 ,pp. :